The Muscle Function Deficit Concept and Inflammaging.
Level 5 - mechanism / opinion, no new human data
Perspective and narrative review describing a conceptual framework and biological mechanisms without presenting new primary data.
PubMed 41751282 · doi:10.3390/biomedicines14020383
What was done
This perspective paper conceptualizes age-related muscle decline through the framework of Skeletal Muscle Function Deficit (SMFD), which unifies muscle quality and mass into a functional definition encompassing sarcopenia, dynapenia, myosteatosis, and powerpenia. The authors outline the application of an SMFD score in the InCHIANTI study across various geriatric outcomes and review mechanistic pathways linking chronic low-grade inflammation (inflammaging) to neuromuscular deterioration.
What was found
The abstract reports no numerical findings or statistical estimates. Qualitatively, it states that the SMFD score has been adopted in the InCHIANTI study to evaluate disability risk, physical performance, hospitalizations, falls, and disease incidence, and describes biological pathways through which inflammatory mediators disrupt anabolic/catabolic balance, accelerate myosteatosis, impair neuromuscular junctions, and drive denervation across cortical motor circuits, spinal motor neurons, peripheral nerves, and muscle fibers.
Why it matters
This framework integrates multiple distinct manifestations of neuromuscular aging into a unified functional model linked to underlying chronic inflammation, aiding risk stratification and intervention design.
Limits
The paper is a conceptual perspective rather than a primary empirical study or systematic review. The abstract provides no sample size, statistical metrics, or comparative validity data for the SMFD score relative to standard sarcopenia diagnostic criteria.
Cited by
- context Aging and metabolic dysfunction lead to fatty infiltration of skeletal muscle, which causes degradation and atrophy of neuromuscular junctions and nerves.